Yayın: Pharmacokinetics of ceftriaxone following single ascending intravenous doses in sheep
| dc.contributor.author | Corum, Duygu Durna | |
| dc.contributor.author | Corum, Orhan | |
| dc.contributor.author | Altan, Feray | |
| dc.contributor.author | Eser Faki, Hatice | |
| dc.contributor.author | Bahcivan, Emre | |
| dc.contributor.author | Er, Ayse | |
| dc.contributor.author | Uney, Kamil | |
| dc.date.accessioned | 2026-01-04T12:26:57Z | |
| dc.date.issued | 2018-12-01 | |
| dc.description.abstract | Abstract The objective of this study was to evaluate the pharmacokinetics of CTX following intravenous administration of ascending doses in sheep. In this study, six clinically healthy Akkaraman sheep (2.4 ± 0.4 years and 50 ± 3 kg of body weight) were used. CTX was administered intravenously to each sheep at 20, 40, and 80 mg/kg doses in a crossover design with a 15-day washout period. Plasma concentrations of CTX were measured using the high-performance liquid chromatography-UV method. Pharmacokinetic parameters were calculated by non-compartmental analysis. CTX was well tolerated following administration at 20, 40, and 80 mg/kg doses. The elimination half-life following administration of 40 and 80 mg/kg doses were significantly longer than that of 20 mg/kg dose (P 0.05). When compared to 20 mg/kg, dose-normalized AUC0–∞ at the 80 mg/kg dose significantly increased (P minimum inhibitory concentration (MIC) of >40% for the treatment of infections caused by bacteria with MIC values ≤2, ≤4, and ≤16 μg/mL, respectively. This information may be helpful in adjusting the dosage regimen, but there is a need for future work. | |
| dc.description.uri | https://doi.org/10.1016/j.smallrumres.2018.07.019 | |
| dc.description.uri | https://dx.doi.org/10.1016/j.smallrumres.2018.07.019 | |
| dc.description.uri | https://avesis.deu.edu.tr/publication/details/c313c3b5-34a8-4efc-b60e-bea1c3fc7aa3/oai | |
| dc.description.uri | https://hdl.handle.net/11468/16048 | |
| dc.description.uri | https://hdl.handle.net/20.500.12395/36840 | |
| dc.identifier.doi | 10.1016/j.smallrumres.2018.07.019 | |
| dc.identifier.endpage | 112 | |
| dc.identifier.issn | 0921-4488 | |
| dc.identifier.openaire | doi_dedup___::e866d27f8532e0258431577013114ad8 | |
| dc.identifier.orcid | 0000-0003-3168-2510 | |
| dc.identifier.orcid | 0000-0002-9017-763x | |
| dc.identifier.orcid | 0000-0002-4415-1738 | |
| dc.identifier.orcid | 0000-0002-8674-4873 | |
| dc.identifier.scopus | 2-s2.0-85050946317 | |
| dc.identifier.startpage | 108 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12597/37053 | |
| dc.identifier.volume | 169 | |
| dc.identifier.wos | 000454968700018 | |
| dc.language.iso | eng | |
| dc.publisher | Elsevier BV | |
| dc.relation.ispartof | Small Ruminant Research | |
| dc.rights | CLOSED | |
| dc.subject | Sheep | |
| dc.subject | Ceftriaxone | |
| dc.subject | Pharmacokinetics | |
| dc.subject | Ascending Dose | |
| dc.subject | Ascending dose | |
| dc.subject.sdg | 3. Good health | |
| dc.title | Pharmacokinetics of ceftriaxone following single ascending intravenous doses in sheep | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.import.source | OpenAire | |
| local.indexed.at | WOS | |
| local.indexed.at | Scopus |
